Tagrisso (Osimertinib Mesylate)

Tagrisso Information:

Buy Tagrisso

Tagrisso (Osimertinib Mesylate) is a medication used to treat non-small cell lung cancer (NSCLC), if the cancer cells are positive for the T790M mutation in the epidermal growth factor receptor (EGFR). Your doctor will do a test to determine whether or not you have this receptor mutation. It belongs to a class of medications called third-generation tyrosine kinase inhibitors. Tagrisso works by binding to proteins made by the EGFR receptor with the T790M mutation, which are responsible for growth and reproduction of the cancer cells. By binding to and inhibiting the actions of these proteins, Tagrisso is able to prevent the growth and reproduction of more cancer cells.

Tagrisso from Canada

Canada Drugs Online is proud to offer you the brand Tagrisso from Canada and the United Kingdom manufactured by AstraZeneca. It is available in the dosages of 40 mg and 80 mg tablets. The generic alternative, Osimertinib, is not available. Please call us toll free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other cancer medications such as Imbruvica and Lynparza.

Tagrisso Side Effects:

Common side effects of Tagrisso may include mouth sores, loss of appetite, diarrhea, feeling tired, dry skin, rash, or tenderness, discoloration, infection, or other problems with your fingernails or toenails.

Contact your doctor immediately if you notice more serious side effects such as:

• A lightheaded feeling, like you might pass out;
• Eye problems (vision changes, watery eyes, increased sensitivity to light, eye pain or redness);
• Fast or pounding heartbeats;
• Shortness of breath, even with mild exertion;
• Signs of new or worsening lung symptoms (sudden chest pain or discomfort, wheezing, dry cough, feeling short of breath);
• Swelling, rapid weight gain

This is not a complete list of side effects. If you notice any other side effects not listed here, please contact your doctor or pharmacist.

Tagrisso Directions:

Take Tagrisso exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Tagrisso is usually given once per day. You may take this medication with or without food. To make swallowing easier, you may place the tablet in a glass with about four tablespoons of water. Stir until the tablet is mostly dissolved and drink this mixture right away. Add 4 to 8 more ounces of water to the glass, swirl gently and drink right away. You may need frequent blood tests while taking this medication. Your heart function may also need to be checked using an electrocardiograph or ECG (sometimes called an EKG) Tagrisso is usually given until your body no longer responds to the medication. Store at room temperature, away from moisture and heat. Keep out of sight and reach of children.

Tagrisso Precautions:

You should not use Tagrisso if you are allergic to Osimertinib. To make sure Tagrisso is safe for you, tell your doctor if you have ever had a breathing disorder not connected to your cancer, an electrolyte imbalance (such as high or low levels of calcium, potassium, or magnesium), eye problems, or long QT syndrome (in you or a family member). Tagrisso can harm an unborn baby if the mother or the father is using this medication. If you are a woman, do not use Tagrisso if you are pregnant. Use effective birth control to prevent pregnancy during use and for at least 6 weeks after your last dose. If you are a man, use effective birth control if your sex partner is able to become pregnant, and for at least 4 months after your last dose. Tell your doctor immediately if pregnancy occurs while either the mother or father is using this medication. You should not breastfeed while using this medication, and for at least 2 weeks after your last dose. Tagrisso may interact with several medications, especially antifungal medications, antibiotic medications, and antiviral medications. This is not a complete list of interactions and others may occur. Tell your doctor about any medications, vitamins, or herbal supplements you are currently taking or have recently taken in order to reduce the risk of any possible interactions. Medication is not approved for use in children under the age of 18.